- Home
- ETNB vs IRS Comparison
ETNB vs IRS Comparison
Compare ETNB & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- IRS
- Stock Information
- Founded
- ETNB 2018
- IRS 1943
- Country
- ETNB United States
- IRS Argentina
- Employees
- ETNB N/A
- IRS N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- ETNB Health Care
- IRS Real Estate
- Exchange
- ETNB Nasdaq
- IRS Nasdaq
- Market Cap
- ETNB 1.0B
- IRS 1.1B
- IPO Year
- ETNB 2019
- IRS 1994
- Fundamental
- Price
- ETNB $10.05
- IRS $15.19
- Analyst Decision
- ETNB Strong Buy
- IRS Strong Buy
- Analyst Count
- ETNB 8
- IRS 1
- Target Price
- ETNB $26.43
- IRS $12.62
- AVG Volume (30 Days)
- ETNB 2.1M
- IRS 137.3K
- Earning Date
- ETNB 05-01-2025
- IRS 05-06-2025
- Dividend Yield
- ETNB N/A
- IRS 10.81%
- EPS Growth
- ETNB N/A
- IRS N/A
- EPS
- ETNB N/A
- IRS 0.20
- Revenue
- ETNB N/A
- IRS $308,539,877.00
- Revenue This Year
- ETNB N/A
- IRS N/A
- Revenue Next Year
- ETNB N/A
- IRS N/A
- P/E Ratio
- ETNB N/A
- IRS $6.78
- Revenue Growth
- ETNB N/A
- IRS N/A
- 52 Week Low
- ETNB $4.16
- IRS $7.93
- 52 Week High
- ETNB $11.84
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- ETNB 68.44
- IRS 52.08
- Support Level
- ETNB $8.94
- IRS $14.87
- Resistance Level
- ETNB $9.70
- IRS $15.90
- Average True Range (ATR)
- ETNB 0.73
- IRS 0.61
- MACD
- ETNB 0.14
- IRS -0.09
- Stochastic Oscillator
- ETNB 93.78
- IRS 15.56
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.